By API User
Sydney, Australia – 5 August 2024 | LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that its innovative nasal spray treatment for Erectile Dysfunction (ED), named SPONTAN®, has been prescribed to the first patients under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS). This milestone represents a significant step … Continued
By API User
New research by Australian biotechnology company Magellan Stem Cells has demonstrated potential for significant therapeutic benefits of an off-the-shelf donor stem cell therapy for Osteoarthritis. The Phase I/II clinical trial assessed the safety and efficacy of MAG200, Magellan Stem Cells’ off-the-shelf allogeneic (donor) stem cell therapy for osteoarthritis of the knee. “Our research indicates that … Continued
By API User
Sydney, Australia – 24 July 2024 – LTR Pharma Limited (ASX: LTP) (“LTR Pharma” or “the Company”), a company focused on improving men’s health through the clinical development and commercialisation of an innovative nasal spray treatment for Erectile Dysfunction (“ED”) called SPONTAN®, is pleased to announce the successful completion of a A$10.5 million share placement … Continued
By API User
La Trobe University is paving the way for Australian food security, with the establishment of a new institute that will expand cutting-edge agricultural research and innovation. The La Trobe Institute for Sustainable Agriculture and Food (LISAF) officially launched today (23 July), to undertake research and innovation across the agri-food-health chain, aiming to enhance profitability for … Continued
By API User
Genomic technologies to discover biological markers, within the blood, that could predict patient response to psychedelic medicines such as psilocybin. MELBOURNE, AUSTRALIA, 22 July 2024 – Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the winner of the annual Australasian Neuroscience Society (ANS) Illumina Neurogenomics Research Award … Continued
By API User
A new study led by Monash University has revealed that medicine strategies following a heart attack vary from patient to patient, despite clear clinical guidelines which should apply to all heart attack patients during this period. The researchers from Monash’s Centre for Medicine Use and Safety (CMUS) analysed post-discharge dispensing of secondary prevention medications among 15,339 … Continued
By API User
LUXEMBOURG / ACCESSWIRE / July 15, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a Molecular Farming ingredient company, announced today the signing of an offtake agreement with one of the largest global consumer packaged goods and pet food companies for the use of Moolec’s patented science-based GLA Safflower Oil product, GLASO™ (the "Agreement"). This … Continued
By API User
What: Victorian Government Minister Colin Brooks, representing the Minister for Training and Skills Gayle Tierney, and La Trobe University Vice-Chancellor Professor Theo Farrell, will Launch the new $8 million state-of-the-art Bio Innovation Hub at La Trobe’s Melbourne campus in Bundoora. The purpose-built facility will support the development of world-leading biotechnology and agri–technology businesses. It includes PC2 “wet” laboratories … Continued
By API User
AMSTERDAM, July 10, 2024 (GLOBE NEWSWIRE) — This randomized, controlled trial was conducted at a tertiary IVF center, Ho Chi Minh City, Vietnam. Between January 2023 and June 2023, 120 women were randomized. Eligible women were aged 18–37 years with polycystic ovarian syndrome (PCOS). After providing written informed consent, participants were randomized (1:1) to undergo … Continued
By API User
New Medicines Manufacturing Innovation Centre opens: Monash accelerates medical innovation and development of life-saving treatments Victorian Deputy Premier and Minister for Medical Research the Hon Ben Carroll today officially opened the newly built Medicines Manufacturing Innovation Centre (MMIC) within the heart of the Monash Technology Precinct, Clayton. Funded through an $8.58 million investment … Continued
